Back to funds
View filing
Venrock Adviser, LLC
hedge fundUpdated 27 days agoManaged by Vr Adviser, Llc • Latest filing Q2 2026
Portfolio value
$3.3B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
64.8%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 17 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q2 2022 | $507.8M |
| Q3 2022 | $648.1M |
| Q4 2022 | $593.6M |
| Q1 2023 | $512.2M |
| Q2 2023 | $625.4M |
| Q3 2023 | $949.9M |
| Q4 2023 | $1.5B |
| Q1 2024 | $2.1B |
| Q2 2024 | $1.6B |
| Q3 2024 | $1.9B |
| Q4 2024 | $1.5B |
| Q1 2025 | $1.2B |
| Q2 2025 | $1.3B |
| Q3 2025 | $1.8B |
| Q4 2025 | $2B |
| Q1 2026 | $2.7B |
| Q2 2026 | $3.3B |
Top holdings
33 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A APGE APOGEE THERAPEUTICS INC | $1.1B | 8.49M | 34.18% | — |
| 2 | O ORKA ORUKA THERAPEUTICS INC | $394.8M | 4.15M | 11.97% | — |
| 3 | E EQR ERASCA INC | $327.8M | 17.89M | 9.94% | — |
| 4 | S SYRE SPYRE THERAPEUTICS INC | $265M | 2.99M | 8.04% | — |
| 5 | D DNTH DIANTHUS THERAPEUTICS INC | $115M | 1.18M | 3.49% | — |
| 6 | O OCFC OCULAR THERAPEUTIX INC | $101.6M | 10.35M | 3.08% | — |
| 7 | ? N/A DAMORA THERAPEUTICS INC | $93.7M | 3.60M | 2.84% | — |
| 8 | S SVRA SAVARA INC | $90.8M | 14.75M | 2.75% | — |
| 9 | J JBIO JADE BIOSCIENCES INC | $71.6M | 3.22M | 2.17% | — |
| 10 | C COGT COGENT BIOSCIENCES INC | $63.6M | 1.64M | 1.93% | — |
| 11 | V VRDN VIRIDIAN THERAPEUTICS INC | $59.8M | 3.26M | 1.81% | — |
| 12 | V VOR VOR BIOPHARMA INC | $56M | 3.04M | 1.70% | — |
| 13 | D DYN DYNE THERAPEUTICS INC | $48.3M | 2.17M | 1.46% | — |
| 14 | M MAZE MAZE THERAPEUTICS INC | $47.8M | 1.60M | 1.45% | — |
| 15 | R RLMD RELMADA THERAPEUTICS INC | $47.4M | 6.84M | 1.44% | — |
| 16 | O ORIC ORIC PHARMACEUTICALS INC | $46.8M | 4.32M | 1.42% | — |
| 17 | ? N/A CRESCENT BIOPHARMA INC. | $38.4M | 2.13M | 1.16% | — |
| 18 | Z ZURA ZURA BIO LTD | $38M | 6.43M | 1.15% | — |
| 19 | A ANL ADLAI NORTYE LTD | $36.9M | 3.21M | 1.12% | — |
| 20 | E ELVN ENLIVEN THERAPEUTICS INC | $26.7M | 526.3K | 0.81% | — |